Sub-acute toxicity studies on the aqueous extract of Stereospermum kunthianum (Cham, Sandrine Petit) stem bark
Abstract
Stereospermum kunthianum Cham, Sandrine Petit (Bignoniaceae) is used in traditional medicine in the treatment of various diseases including bronchitis, rheumatoid arthritis, dysentery, ulcers etc. The aqueous stem bark extract of the plant was evaluated for its acute and subacute (28-day) toxicity in rats. The subacute effects of the extract (0.5, 1 and 2g/kg, p.o.) were evaluated on the following parameters, namely: alanine aminotransferase (ALT), alkaline phosphatase (ALP), total cholesterol, low density lipoprotein (LDL) and high density lipoprotein (HDL)-cholesterol, triglycerides as well as organ weight and histopathologic changes. In the acute toxicity studies, no adverse behavioural effects or mortality were observed up to a dose of 8000mg/kg. No significant changes were observed in the serum and liver enzymes (ALT and ALP) except for an increase in the serum ALT levels at the highest dose (2g/kg) of the extract. Significant increases in triglyceride, total cholesterol, LDL- and HDL- cholesterol levels were also recorded with the dose of 2g/kg. Increases of the organ (liver, kidney, heart and spleen) weights were produced with all doses of Stereospermum kunthianum but histological alterations of these organs were observed with only the highest dose. From the results obtained, it is concluded that Stereospermum kunthianum up to a dose of 1000mg/kg may be safe for long term treatment of various ailments.
Keywords: Stereospermum kunthianum; Subacute toxicity; Histopathology, Lipid profile
Copyright of articles published shall reside exclusively with the Faculty of Pharmaceutical Sciences, University of Jos.
DECLARATION & COPYRIGHT TRANSFER
I/We the undersigned author(s) of article entitled
…………………………………………………………………………………………………………………
…………………………………………………………………………………………………………………
Declare as follows:
- The manuscript submitted to Journal of Pharmacy & Bioresources is original and has not been and will be published, whole or in part, in print or electronic format, in any other journal. It is also not being currently considered for publication in any journal.
- The submitted manuscript is a joint decision of all the coauthors.
- Each author has participated sufficiently in the work to warrant his or her inclusion in the list of authors. To this end, each author takes responsibility for appropriate portions of the manuscript.
- Authors have obtained necessary approval to carry out the experiments on animals and human subjects. Approval certificates will be furnished, if required by publishers or editors of the journal.
- Authors do not have any conflict of interest (financial or otherwise) other than those declared.
- If the manuscript is accepted for publication, the authors transfer and assign copyright of the article referenced above to Journal of Pharmacy and Bioresources.
Name & Signature of authors
1. 2.
- 4.
- 6.
- 8.
Corresponding authors name address, affiliation and email:
